Optimal stratification in outcome prediction using baseline information
暂无分享,去创建一个
L. Tian | L. J. Wei | T. Cai | Sheng Yu | F. H. Yong
[1] Lihui Zhao,et al. A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies. , 2016, Biometrics.
[2] Lihui Zhao,et al. Predicting the restricted mean event time with the subject's baseline covariates in survival analysis. , 2014, Biostatistics.
[3] Lu Tian,et al. Classical Model Selection , 2013 .
[4] Lu Tian,et al. Effectively Selecting a Target Population for a Future Comparative Study , 2013, Journal of the American Statistical Association.
[5] Patrick Royston,et al. A simulation study of predictive ability measures in a survival model I: Explained variation measures , 2012, Statistics in medicine.
[6] P Royston,et al. A simulation study of predictive ability measures in a survival model II: explained randomness and predictive accuracy , 2012, Statistics in medicine.
[7] P. Royston,et al. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt , 2011, Statistics in medicine.
[8] Wei-Yin Loh,et al. Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..
[9] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[10] Hamdy A. Taha,et al. Operations research: an introduction / Hamdy A. Taha , 1982 .
[11] S. Solomon,et al. Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial , 2006, Circulation.
[12] Patrick Royston,et al. Explained Variation for Survival Models , 2006 .
[13] M. Pfeffer,et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. , 2004, The New England journal of medicine.
[14] Yi-Zeng Liang,et al. Monte Carlo cross validation , 2001 .
[15] Eyton,et al. A CONTROLLED TRIAL OF TWO NUCLEOSIDE ANALOGUES PLUS INDINAVIR IN PERSONS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND CD4 CELL COUNTS OF 200 PER CUBIC MILLIMETER OR LESS , 2000 .
[16] E Graf,et al. Assessment and comparison of prognostic classification schemes for survival data. , 1999, Statistics in medicine.
[17] Shinichi Morishita,et al. On Classification and Regression , 1998, Discovery Science.
[18] David M. Zucker,et al. Restricted Mean Life with Covariates: Modification and Extension of a Useful Survival Analysis Method , 1998 .
[19] M A Fischl,et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. , 1997, The New England journal of medicine.
[20] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[21] Norman Breslow,et al. Discussion of Professor Cox''s paper , 1974 .
[22] D. Cox. Regression Models and Life-Tables , 1972 .
[23] D.,et al. Regression Models and Life-Tables , 2022 .